Follow this preprint
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan
Yuto Takeuchi, View ORCID ProfileYusaku Akashi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, Atsuo Ueda, Shigeyuki Notake, Koji Nakamura, Hiroichi Ishikawa, Hiromichi Suzuki
doi: https://doi.org/10.1101/2020.12.27.20248876
Now published in Journal of Infection and Chemotherapy doi: 10.1016/j.jiac.2021.02.029
Yuto Takeuchi
aDepartment of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan
bDivision of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
Yusaku Akashi
bDivision of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
cAkashi Internal Medicine Clinic, 3-1-63 Asahigaoka, Kashiwara, Osaka 582-0026, Japan
Daisuke Kato
dDenka Co., Ltd. Gosen site, Reaserch & Development Division, Reagent R&D Depertment, 1-2-2 Minami-hon-cho, Gosen-shi, Niigata 959-1695, Japan
Miwa Kuwahara
dDenka Co., Ltd. Gosen site, Reaserch & Development Division, Reagent R&D Depertment, 1-2-2 Minami-hon-cho, Gosen-shi, Niigata 959-1695, Japan
Shino Muramatsu
dDenka Co., Ltd. Gosen site, Reaserch & Development Division, Reagent R&D Depertment, 1-2-2 Minami-hon-cho, Gosen-shi, Niigata 959-1695, Japan
Atsuo Ueda
eDepartment of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Shigeyuki Notake
eDepartment of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Koji Nakamura
eDepartment of Clinical Laboratory, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Hiroichi Ishikawa
fDepartment of Respiratory Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo, Tsukuba, Ibaraki 305-8558, Japan
Hiromichi Suzuki
aDepartment of Infectious Diseases, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576, Japan
bDivision of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital, 1-3-1 Amakubo Tsukuba, Ibaraki 305-8558, Japan
gDepartment of Infectious Diseases, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

Data Availability
The data are not publicly available due to their containing information that could compromise the privacy of research participants.
Posted January 03, 2021.
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan
Yuto Takeuchi, Yusaku Akashi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, Atsuo Ueda, Shigeyuki Notake, Koji Nakamura, Hiroichi Ishikawa, Hiromichi Suzuki
medRxiv 2020.12.27.20248876; doi: https://doi.org/10.1101/2020.12.27.20248876
Now published in Journal of Infection and Chemotherapy doi: 10.1016/j.jiac.2021.02.029
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3204)
- Dermatology (270)
- Emergency Medicine (475)
- Epidemiology (13202)
- Forensic Medicine (19)
- Gastroenterology (884)
- Genetic and Genomic Medicine (5029)
- Geriatric Medicine (469)
- Health Economics (769)
- Health Informatics (3164)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (996)
- Medical Education (467)
- Medical Ethics (124)
- Nephrology (512)
- Neurology (4774)
- Nursing (253)
- Nutrition (706)
- Oncology (2460)
- Ophthalmology (697)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1272)
- Primary Care Research (545)
- Public and Global Health (7338)
- Radiology and Imaging (1659)
- Respiratory Medicine (960)
- Rheumatology (470)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (197)